A potential novel stratification model to predict cardiovascular disease in patients with metabolic dysfunction-associated steatotic liver disease

Thomas Bülow Pedersen; Martin Bødtker Mortensen; Henning Grønbæk

doi:10.1016/j.ejim.2024.09.005

A potential novel stratification model to predict cardiovascular disease in patients with metabolic dysfunction-associated steatotic liver disease

Eur J Intern Med. 2024 Nov:129:33-34. doi: 10.1016/j.ejim.2024.09.005. Epub 2024 Sep 14.

Authors

Thomas Bülow Pedersen¹, Martin Bødtker Mortensen², Henning Grønbæk³

Affiliations

¹ Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
² Department of Cardiology, Aarhus Uniaversity Hospital, Aarhus, Denmark.
³ Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: [email protected].

PMID: 39277484
DOI: 10.1016/j.ejim.2024.09.005

No abstract available

Keywords: Cardiovascular disease (CVD); Major adverse cardiac events (MACE); Metabolic dysfunction-associated steatohepatitis (MASH); Metabolic dysfunction-associated steatotic liver disease (MASLD).